发明名称 Composition for prevention or treatment of cancer comprising N-methylenenaphtho[2,1-<i>b</i>]furan-2-carbohydrazide derivatives as an active ingredient
摘要 The present invention relates to ethyl(2-methyl-3{(E)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1H-indole-1-yl)acetate, the novel mitosis inhibitor. The said ethyl(2-methyl-3{(E)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1H-indole-1-yl)acetate not only induces apoptosis by inhibiting tubulin polymerization in the course of mitosis but also displays an excellent anticancer effect in the multi-drug resistant cancer cells, so that it can be effectively used for the treatment of cell proliferative disease including various cancers.
申请公布号 US9433607(B2) 申请公布日期 2016.09.06
申请号 US201514641065 申请日期 2015.03.06
申请人 Korea Research Institute of Bioscience and Biotechnology 发明人 Kim Bo Yeon;Sakchaisri Krisada;Kim Sun Ok;Naraganahalli Ramegowda Thimmegowda;Soung Nak Kyun;Ahn Jong Seog;Hwang Joonsung;Ryoo In Ja;Jang Jae-Hyuk
分类号 A61K31/40;A61K31/405;A61K31/34;A61K31/343;A61K31/4045 主分类号 A61K31/40
代理机构 Klarquist Sparkman, LLP 代理人 Klarquist Sparkman, LLP
主权项 1. A method of treating cancer, comprising administering a pharmaceutically effective dose of a compound represented by the below formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient to a subject having cancer: wherein R1 is wherein R2 is methyl, R3 is methyl, allyl, cyanomethyl or —CH2(C═O)OCH2CH3, and R4 is nitro, 4-bromophenyl, 2,3-dichlorophenyl, 4-nitrophenyl or 4-methyl-3-nitrophenyl.
地址 Daejeon KR